These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24397608)

  • 41. Structural and functional basis for the long QT syndrome: relevance to veterinary patients.
    Finley MR; Lillich JD; Gilmour RF; Freeman LC
    J Vet Intern Med; 2003; 17(4):473-88. PubMed ID: 12892298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
    Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
    Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An explainable algorithm for detecting drug-induced QT-prolongation at risk of torsades de pointes (TdP) regardless of heart rate and T-wave morphology.
    Alahmadi A; Davies A; Royle J; Goodwin L; Cresswell K; Arain Z; Vigo M; Jay C
    Comput Biol Med; 2021 Apr; 131():104281. PubMed ID: 33636421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arrhythmogenic mechanisms of QT prolonging drugs: is QT prolongation really the problem?
    Antzelevitch C
    J Electrocardiol; 2004; 37 Suppl():15-24. PubMed ID: 15534788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A wearable remote monitoring system for the identification of subjects with a prolonged QT interval or at risk for drug-induced long QT syndrome.
    Castelletti S; Dagradi F; Goulene K; Danza AI; Baldi E; Stramba-Badiale M; Schwartz PJ
    Int J Cardiol; 2018 Sep; 266():89-94. PubMed ID: 29887480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacotherapy in inherited and acquired ventricular arrhythmia in structurally normal adult hearts.
    Ortmans S; Daval C; Aguilar M; Compagno P; Cadrin-Tourigny J; Dyrda K; Rivard L; Tadros R
    Expert Opin Pharmacother; 2019 Dec; 20(17):2101-2114. PubMed ID: 31566420
    [No Abstract]   [Full Text] [Related]  

  • 49. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.
    De Ponti F; Poluzzi E; Montanaro N
    Eur J Clin Pharmacol; 2000 Apr; 56(1):1-18. PubMed ID: 10853872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
    Calderone V; Cavero I
    Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias.
    Cavero I; Mestre M; Guillon JM; Crumb W
    Expert Opin Pharmacother; 2000 Jul; 1(5):947-73. PubMed ID: 11249502
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation.
    Baracaldo-Santamaría D; Llinás-Caballero K; Corso-Ramirez JM; Restrepo CM; Dominguez-Dominguez CA; Fonseca-Mendoza DJ; Calderon-Ospina CA
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. QT prolongation and safety in the Indian population.
    Dabhi J; Mehta A
    Curr Drug Saf; 2007 Sep; 2(3):200-3. PubMed ID: 18690968
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
    Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
    Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological approach to the treatment of long and short QT syndromes.
    Patel C; Antzelevitch C
    Pharmacol Ther; 2008 Apr; 118(1):138-51. PubMed ID: 18378319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired long QT syndrome: a focus for the general pediatrician.
    Marzuillo P; Benettoni A; Germani C; Ferrara G; D'Agata B; Barbi E
    Pediatr Emerg Care; 2014 Apr; 30(4):257-61. PubMed ID: 24694881
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.
    Schutte D; Obel W
    Cardiovasc J S Afr; 2002; 13(2):54-61. PubMed ID: 11981581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSAHi study: Evaluation of multi-electrode array in combination with human iPS cell-derived cardiomyocytes to predict drug-induced QT prolongation and arrhythmia--effects of 7 reference compounds at 10 facilities.
    Kitaguchi T; Moriyama Y; Taniguchi T; Ojima A; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Morita M; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Tanaka K; Washio I; Miyamoto N
    J Pharmacol Toxicol Methods; 2016; 78():93-102. PubMed ID: 26657830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Autoantibodies with beta-adrenergic activity from chronic chagasic patients induce cardiac arrhythmias and early afterdepolarization in a drug-induced LQT2 rabbit hearts.
    Jiménez MAV; Nascimento JHM; Monnerat G; Maciel L; Paiva CN; Pedrosa RC; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2017 Aug; 240():354-359. PubMed ID: 28320606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of QT-prolonging medications in US emergency departments, 1995-2009.
    Tay KY; Ewald MB; Bourgeois FT
    Pharmacoepidemiol Drug Saf; 2014 Jan; 23(1):9-17. PubMed ID: 23696066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.